Lysarc partners with veeva to accelerate innovation for lymphoma treatments

Pleasanton, calif., jan. 20, 2022 /prnewswire/ -- veeva systems (nyse: veev) today announced that the lymphoma academic research organization (lysarc) selected veeva development cloud to improve operational efficiency across its lymphoma therapy research.

VEEV Ratings Summary

VEEV Quant Ranking